This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Dentognostics Gmbh, Oy Medix Biochemica Ab. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
2 out of 12 Years Active: 2019-2022
Title: Kurt Maier: Innovator in MMP-8 Activation Products
Introduction
Kurt Maier is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biochemistry, particularly in the area of MMP-8 activation products. With a total of 2 patents, his work has implications for diagnosing diseases related to abnormal levels of activated MMP-8.
Latest Patents
Kurt Maier's latest patents include innovative methods for detecting MMP-8 activation products. One of his patents focuses on a novel MMP-8 activation product, specifically a middle-part activation product. This invention relates to the detection of such products or activated MMP-8 fragments in biological samples. The methods he developed are crucial for diagnosing diseases associated with elevated levels of activated MMP-8. Another patent also addresses MMP-8 activation products, detailing their size and methods for detection in biological samples.
Career Highlights
Throughout his career, Kurt Maier has worked with various companies, including Medix Biochemica and Dentognostics. His experience in these organizations has allowed him to refine his expertise in biochemistry and patent development. His contributions have been instrumental in advancing the understanding of MMP-8 and its clinical applications.
Collaborations
Kurt Maier has collaborated with notable professionals in his field, including Timo Arto Sorsa and Dirk-Rolf Gieselmann. These collaborations have enriched his research and contributed to the development of his patents.
Conclusion
Kurt Maier's work in MMP-8 activation products showcases his innovative spirit and dedication to advancing medical diagnostics. His patents reflect a commitment to improving healthcare through scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile